Establishing in vivo proof of concept of brown adipogenesis using approved drugs
Ended Project Grant Awarded Last action
- Award ID
- R44DK109860
- Recipient
-
Energesis Pharmaceuticals Inc. UEI JA9AEU5KN7R1
- Awarding agency
-
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,781,519
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Originally
- Place of performance
- Cambridge, MA 02139, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $969,332 | |
| Original award | $812,187 |
Quick answers
Who received award R44DK109860?
R44DK109860 was awarded to Energesis Pharmaceuticals Inc. by National Institute of Diabetes and Digestive and Kidney Diseases (National Institutes of Health) on June 20, 2016.
How much is award R44DK109860 worth?
$1,781,519 has been obligated on R44DK109860.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award